Legend: : Special Mention : Important ![]() : Very Important ![]() ![]() : Key Development |
||
![]() |
Helicobacter pylori: diagnosis and treatment. Selgrad M, Kandulski A, Malfertheiner P, Curr Opin Gastroenterol. 2009 Nov;25(6):549-56 |
|
![]() |
Review article: Helicobacter pylori-negative duodenal ulcer disease. Gisbert JP, Calvet X, Aliment Pharmacol Ther. 2009 Oct 15;30(8):791-815 |
|
![]() |
Helicobacter pylori infection in pediatrics. Kindermann A, Lopes AI, Helicobacter. 2009 Sep;14 Suppl 1:52-7 |
|
![]() |
Treatment of Helicobacter pylori infection. O'Connor A, Gisbert J, O'Morain C, Helicobacter. 2009 Sep;14 Suppl 1:46-51 |
|
![]() |
Helicobacter pylori and clinical aspects of gastric cancer. Bornschein J, Rokkas T, Selgrad M, Malfertheiner P, Helicobacter. 2009 Sep;14 Suppl 1:41-5 |
|
![]() |
Helicobacter pylori and non-malignant diseases. Furuta T, Delchier JC, Helicobacter. 2009 Sep;14 Suppl 1:29-35 |
|
![]() |
Inflammation, immunity, and vaccines for Helicobacter pylori. D'Elios MM, Andersen LP, Helicobacter. 2009 Sep;14 Suppl 1:21-8 |
|
![]() |
Clinical significance of IgG antibody titer against Helicobacter pylori. Tatemichi M, Sasazuki S, Inoue M, Tsugane S, JPHC Study Group, Helicobacter. 2009 Jun;14(3):231-6 |
|
![]() |
Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Kabir S, Helicobacter. 2009 Jun;14(3):159-71 |
|
![]() |
Helicobacter pylori and gastric carcinogenesis. Hatakeyama M, J Gastroenterol. 2009;44(4):239-48 |
|
![]() |
Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Ikeda F, Doi Y, Yonemoto K, Ninomiya T, Kubo M, Shikata K, Hata J, Tanizaki Y, Matsumoto T, Iida M, Kiyohara Y, Gastroenterology. 2009 Apr;136(4):1234-41 |
|
![]() |
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Kim SS, Ruiz VE, Carroll JD, Moss SF., Cancer Lett. 2011 Jun 28;305(2):228-38. Epub 2010 Aug 7. |
|
![]() |
Alarm features and age for predicting upper gastrointestinal malignancy inChinese patients with dyspepsia with high background prevalence of Helicobacterpylori infection and upper gastrointestinal malignancy: an endoscopic databasereview of 102,665 patients from 1996 to 2006. Bai Y, Li ZS, Zou DW, Wu RP, Yao YZ, Jin ZD, Ye P, Li SD, Zhang WJ, Du YQ, ZhanXB, Liu F, Gao J, Xu GM., Gut. 2010 Jun;59(6):722-8. |
|
![]() |
Effects of Helicobacter pylori eradication on early stage gastricmucosa-associated lymphoid tissue lymphoma. Zullo A, Hassan C, Cristofari F, Andriani A, De Francesco V, Ierardi E, Tomao S, Stolte M, Morini S, Vaira D., Clin Gastroenterol Hepatol. 2010 Feb;8(2):105-10. Epub 2009 Jul 22. |
|
![]() |
Clinical practice. Helicobacter pylori infection. McColl KE., N Engl J Med. 2010 Apr 29;362(17):1597-604. |
|
![]() |
Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT, Gastroenterology. 2009 Nov;137(5):1641-8.e1-2 |
|
![]() |
Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Yan F, Cao H, Chaturvedi R, Krishna U, Hobbs SS, Dempsey PJ, Peek RM Jr, Cover TL, Washington MK, Wilson KT, Polk DB, Gastroenterology. 2009 Apr;136(4):1297-1307, e1-3 |
|
![]() |
The role of interleukin-17 in the Helicobacter pylori induced infection andimmunity. Kabir S., Helicobacter. 2011 Feb;16(1):1-8. doi: 10.1111/j.1523-5378.2010.00812.x. |
|
![]() |
Helicobacter pylori treatment in the era of increasing antibiotic resistance. Graham DY, Fischbach L., Gut. 2010 Aug;59(8):1143-53. Epub 2010 Jun 4. |
|
![]() |
Systematic review: Helicobacter pylori and the risk of upper gastrointestinalbleeding risk in patients taking aspirin. Fletcher EH, Johnston DE, Fisher CR, Koerner RJ, Newton JL, Gray CS., Aliment Pharmacol Ther. 2010 Oct;32(7):831-9. doi:10.1111/j.1365-2036.2010.04415.x. |
|
![]() |
Update on mucosal immunoglobulin A in gastrointestinal disease. Brandtzaeg P., Curr Opin Gastroenterol. 2010 Nov;26(6):554-63. |
|
![]() |
Gastroduodenal mucosal defense. deFoneska A, Kaunitz JD., Curr Opin Gastroenterol. 2010 Nov;26(6):604-10. |
|
![]() |
Association between Helicobacter pylori infection and inflammatory bowel disease:a meta-analysis and systematic review of the literature. Luther J, Dave M, Higgins PD, Kao JY., Inflamm Bowel Dis. 2010 Jun;16(6):1077-84. |
|
![]() |
Helicobacter pylori treatment in the era of increasing antibiotic resistance. Graham DY, Fischbach L., Gut. 2010 Aug;59(8):1143-53. Epub 2010 Jun 4. |
|
![]() |
The versatility of Helicobacter pylori CagA effector protein functions: Themaster key hypothesis. Backert S, Tegtmeyer N, Selbach M., Helicobacter. 2010 Jun;15(3):163-76. |
|
![]() |
Clinical practice: diagnosis and evaluation of dyspepsia. Graham DY, Rugge M., J Clin Gastroenterol. 2010 Mar;44(3):167-72. |
|
![]() |
Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study. Toyokawa T, Suwaki K, Miyake Y, Nakatsu M, Ando M, J Gastroenterol Hepatol. 2010 Mar;25(3):544-7 |
|
![]() |
Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication. Hung KH, Yang HB, Cheng HC, Wu JJ, Sheu BS, J Gastroenterol Hepatol. 2010 Jan;25(1):48-53 |
|
![]() |
Editorial: Sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn? Moayyedi P, Malfertheiner P, Am J Gastroenterol. 2009 Dec;104(12):3081-3 |
|
![]() |
Multiple gene status in Helicobacter pylori strains and risk of gastric cancer development. Douraghi M, Talebkhan Y, Zeraati H, Ebrahimzadeh F, Nahvijoo A, Morakabati A, Ghafarpour M, Esmaili M, Bababeik M, Oghalaie A, Rakhshani N, Hosseini ME, Mohagheghi MA, Mohammadi M, Digestion. 2009;80(3):200-7 |
|
![]() |
Uncomplicated peptic ulcer in the UK: trends from 1997 to 2005. Cai S, García Rodríguez LA, Massó-González EL, Hernández-Díaz S, Aliment Pharmacol Ther. 2009 Nov 15;30(10):1039-48 |
|
![]() |
Review article: Helicobacter pylori-negative duodenal ulcer disease. Gisbert JP, Calvet X, Aliment Pharmacol Ther. 2009 Oct 15;30(8):791-815 |
|
![]() |
Screening for Barrett's esophagus in asymptomatic women. Gerson LB, Banerjee S, Gastrointest Endosc. 2009 Nov;70(5):867-73 |
|
![]() |
Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers. Musumba C, Pritchard DM, Pirmohamed M, Aliment Pharmacol Ther. 2009 Sep 15;30(6):517-31 |
|
![]() |
Review article: 'true' re-infection of Helicobacter pylori after successful eradication - worldwide annual rates, risk factors and clinical implications. Zhang YY, Xia HH, Zhuang ZH, Zhong J, Aliment Pharmacol Ther. 2009 Jan 15;29(2):145-60 |
|
![]() |
Growth inhibitory action of cranberry on Helicobacter pylori. Matsushima M, Suzuki T, Masui A, Kasai K, Kouchi T, Takagi A, Shirai T, Mine T, J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S175-80 Cat: Journal Article |
|
![]() |
Diagnosis of Helicobacter pylori infection in a high-prevalence pediatric population: a comparison of 2 fecal antigen testing methods and serology. Cherian S, Burgner DP, Carson CF, Sanfilippo FM, Cook AG, Forbes DA, J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):130-5 |
|
![]() |
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study. Hansen JM, Wildner-Christensen M, Hallas J, Schaffalitzky de Muckadell OB, Am J Gastroenterol 2008 May;103(5):1106-13 |
|
![]() |
Evaluation of a novel stool native catalase antigen test for Helicobacter pylori infection in asymptomatic North American children. Cardenas VM, Dominguez DC, Puentes FA, Aragaki CC, Goodman KJ, Graham DY, Fukuda Y, J Pediatr Gastroenterol Nutr 2008 Apr;46(4):399-402 |
|
![]() |
Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Ghoshal UC, Tiwari S, Dhingra S, Pandey R, Ghoshal U, Tripathi S, Singh H, Gupta VK, Nagpal AK, Naik S, Ayyagari A, Dig Dis Sci 2008 May;53(5):1215-22 |
|
![]() |
Sequential therapy for Helicobacter pylori: a worthwhile effort for your patients. Marshall B, Ann Intern Med 2008 Jun 17;148(12):962-3 |
|
| Review article: non-bismuth quadruple (concomitant) therapy for eradication ofHelicobater pylori. Gisbert JP, Calvet X., Aliment Pharmacol Ther. 2011 Sep;34(6):604-17. doi:10.1111/j.1365-2036.2011.04770.x. Epub 2011 Jul 11. |
||
| Gastric epithelial stem cells. Mills JC, Shivdasani RA., Gastroenterology. 2011 Feb;140(2):412-24. Epub 2010 Dec 7. |
||
| Usefulness of magnifying narrow-band imaging endoscopy in the Helicobacterpylori-related chronic gastritis. Okubo M, Tahara T, Shibata T, Nakamura M, Kamiya Y, Yoshioka D, Maeda Y, YonemuraJ, Ishizuka T, Arisawa T, Hirata I., Digestion. 2011;83(3):161-6. Epub 2011 Jan 21. |
||
| Has H. pylori prevalence in bleeding peptic ulcer been underestimated? Ameta-regression. Sánchez-Delgado J, Gené E, Suárez D, García-Iglesias P, Brullet E, Gallach M, FeuF, Gisbert JP, Calvet X., Am J Gastroenterol. 2011 Mar;106(3):398-405. Epub 2011 Feb 8. |
||
| Helicobacter pylori infection and current clinical areas of contention. Malfertheiner P, Selgrad M., Curr Opin Gastroenterol. 2010 Nov;26(6):618-23. |
||
| Involvement of activation-induced cytidine deaminase in the development ofcolitis-associated colorectal cancers. Endo Y, Marusawa H, Chiba T., J Gastroenterol. 2011 Jan;46 Suppl 1:6-10. Epub 2010 Sep 28. |
||
| Pathology of non-Helicobacter pylori gastritis: extending the histopathologichorizons. Lauwers GY, Fujita H, Nagata K, Shimizu M., J Gastroenterol. 2010 Feb;45(2):131-45. Epub 2009 Dec 5. |
||
| Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pyloriinfection: Systematic review and meta-analysis of efficacy and tolerability. Luther J, Higgins PD, Schoenfeld PS, Moayyedi P, Vakil N, Chey WD., Am J Gastroenterol. 2010 Jan;105(1):65-73. Epub 2009 Sep 15. |
||
| Eradication of gastric cancer and more efficient gastric cancer surveillance inJapan: two peas in a pod. Graham DY, Asaka M., J Gastroenterol. 2010;45(1):1-8. Epub 2009 Aug 28. |
||
| The epidemiology of Helicobacter pylori and public health implications. Azevedo NF, Huntington J, Goodman KJ, Helicobacter. 2009 Sep;14 Suppl 1:1-7 |
||
| Presence of thrombin-activatable fibrinolysis inhibitor in Helicobacter pylori-associated gastroduodenal disease. Ikeda A, Gabazza EC, Morser J, Imoto I, Kuroda M, D'Alessandro-Gabazza CN, Hara K, Ruiz DB, Bernabe PG, Katsurahara M, Toda M, Kobayashi Y, Yano Y, Sumida Y, Suzuki K, Taguchi O, Takei Y, Helicobacter. 2009 Apr;14(2):147-55 |
||
| Urea breath test in children: the United States prospective, multicenter study. Elitsur Y, Tolia V, Gilger MA, Reeves-Garcia J, Schmidt-Sommerfeld E, Opekun AR, El-Zimaity H, Graham DY, Enmei K, Helicobacter. 2009 Apr;14(2):134-40 |
||
| Prevalence of Helicobacter pylori infection and identification of risk factors in rural and urban Beijing, China. Cheng H, Hu F, Zhang L, Yang G, Ma J, Hu J, Wang W, Gao W, Dong X, Helicobacter. 2009 Apr;14(2):128-33 |
||
| Comparison of a stool antigen test and serology for the diagnosis of Helicobacter pylori infection in mass survey. Shimoyama T, Oyama T, Matsuzaka M, Danjo K, Nakaji S, Fukuda S, Helicobacter. 2009 Apr;14(2):87-90 |
||
| Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community. Sone Y, Kumada T, Toyoda H, Yokoyama M, Kato M, Asaka M, Helicobacter. 2008 Oct;13(5):346-51 |
||
| Helicobacter pylori and NSAID-induced gastric ulcer in a Japanese population. Murakami K, Okimoto T, Kodama M, Tanahashi J, Yasaka S, Inoue K, Uchida M, Anan J, Mizukami K, Abe T, Watada M, Fujioka T, J Gastroenterol. 2009;44 Suppl 19:40-3 |
||
| Comparison of high resolution magnifying endoscopy and standard videoendoscopy for the diagnosis of Helicobacter pylori gastritis in routine clinical practice: a prospective study. Gonen C, Simsek I, Sarioglu S, Akpinar H, Helicobacter. 2009 Feb;14(1):12-21 |
||
| Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients. Vakil N, Zullo A, Ricci C, Hassan C, Vaira D, Aliment Pharmacol Ther. 2008 Dec 1;28(11-12):1304-8 Cat: Journal Article |
||
| The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. Jang EJ, Park SW, Park JS, Park SJ, Hahm KB, Paik SY, Sin MK, Lee ES, Oh SW, Park CY, Baik HW, J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S278-85 |
||
| Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities. Kawai T, Yamagishi T, Yagi K, Kataoka M, Kawakami K, Sofuni A, Itoi T, Sakai Y, Moriyasu F, Osaka Y, Takagi Y, Aoki T, Rimbara E, Noguchi N, Sasatsu M, J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S171-4 |
||
| Past Rifampicin Dosing Determines Rifabutin Resistance of Helicobacter pylori. Suzuki S, Suzuki H, Nishizawa T, Kaneko F, Ootani S, Muraoka H, Saito Y, Kobayashi I, Hibi T, Digestion. 2009 Jan 14;79(1):1-4 |
||
| Patients with duodenal ulcer have lower levels of serum cholesterol compared to other dyspeptic patients independently of Helicobacter pylori status. Karpouza A, Samouilidou E, Karagiannis S, Kostopoulou V, Sotiropoulou M, Roma E, Petraki K, Michopoulos S, Scand J Gastroenterol. 2008 Aug;43(8):922-8 |
||
| Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer. Kim CG, Choi IJ, Lee JY, Cho SJ, Nam BH, Kook MC, Hong EK, Kim YW, J Gastroenterol Hepatol. 2008 Dec 2; |
||
| Furazolidone, Co-amoxiclav, Colloidal Bismuth Subcitrate, and Esomeprazole for Patients Who Failed to Eradicate Helicobacter pylori with Triple Therapy. Abbas Z, Yakoob J, Abid S, Jafri W, Islam M, Azam Z, Hilal I, Dig Dis Sci. 2008 Dec 5; |
||
| Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Shiotani A, Uedo N, Iishi H, Yoshiyuki Y, Ishii M, Manabe N, Kamada T, Kusunoki H, Hata J, Haruma K, Digestion. 2008;78(2-3):113-9 |
||
| In French Children, Primary Gastritis Is More Frequent Than Helicobacter pylori Gastritis. Kalach N, Papadopoulos S, Asmar E, Spyckerelle C, Gosset P, Raymond J, Dehecq E, Decoster A, Creusy C, Dupont C, Dig Dis Sci. 2008 Nov 12; |
||
| Lack of diagnostic utility of specific immunoglobulin M in Helicobacter pylori infection in children. Serrano CA, Gonzáez CG, Rollan AR, Duarte I, Torres J, Peña AJ, Harris PR, J Pediatr Gastroenterol Nutr. 2008 Nov;47(5):612-7 |
||
| Factors affecting physicians' practices related to Helicobacter pylori infection: effect of experience and mode of practice. Yee YK, Cheung TK, Gu Q, Chan P, But D, Hung IF, Chan CK, Yuen MF, Wong BC, Digestion. 2008;78(2-3):77-81 Cat: Journal Article |
||
| Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease. Saxena A, Nath Prasad K, Chand Ghoshal U, Krishnani N, Roshan Bhagat M, Husain N, Scand J Gastroenterol. 2008;43(6):669-74 |
||
| Does the eradication of Helicobacter pylori delay the diagnosis of gastric cancer? Kokkola A, Sipponen P, Arkkila P, Danielson H, Puolakkainen P, Scand J Gastroenterol. 2008;43(12):1456-60 |
||
| Dyspepsia and Helicobacter pylori. Selgrad M, Kandulski A, Malfertheiner P, Dig Dis 2008;26(3):210-4 |
||
| Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children. T Arenz, D Antos, H Russmann, M Alberer, S Buderus, M Kappler, S Koletzko, J Pediatr Gastroenterol Nutr. 2006 Aug:180-4 |
||
| Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J, Am J Gastroenterol 2008 Mar;103(3):510-4 |
||
| Gastric emptying of solids is slower in functional dyspepsia unrelated to Helicobacter pylori infection in female children and teenagers. Machado RS, Reber M, Patrício FR, Kawakami E, J Pediatr Gastroenterol Nutr 2008 Apr;46(4):403-8 |
||
| Hyperemesis gravidarum and Helicobacter pylori infection: a systematic review. D Golberg, A Szilagyi, L Graves, Obstet Gynecol. 2007 Sep:695-703 |
||
| Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Wei J, O'Brien D, Vilgelm A, Piazuelo MB, Correa P, Washington MK, El-Rifai W, Peek RM, Zaika A, Gastroenterology 2008 May;134(5):1412-23 |
||
| Mechanism for gastric cancer development by Helicobacter pylori infection. Chiba T, Marusawa H, Seno H, Watanabe N, J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1175-81 |
||
| Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries. De Vries AC, Van Driel HF, Richardus JH, Ouwendijk M, Van Vuuren AJ, De Man RA, Kuipers EJ, Scand J Gastroenterol 2008;43(4):403-9 |
||
| Natural history and symptomatology of Helicobacter pylori in childhood and factors determining the epidemiology of infection. A Ozen, D Ertem, E Pehlivanoglu, J Pediatr Gastroenterol Nutr. 2006 Apr:398-404 |
||
| Prevalence of peptic ulcer in dyspeptic patients and the influence of age, sex, and Helicobacter pylori infection. De Vries AC, Van Driel HF, Richardus JH, Ouwendijk M, Van Vuuren AJ, De Man RA, Kuipers EJ, Dig Dis Sci 2008 Oct;53(10):2650-6 |
||
| 'Rescue' therapies for the management of Helicobacter pylori infection. F Di Mario, LG Cavallaro, C Scarpignato, Dig Dis. 2006:113-30 |
||
| Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression. P Malfertheiner, R Fass, EM Quigley, IM Modlin, JR Malagelada, SF Moss, G Holtmann, KL Goh, P Katelaris, V Stanghellini, NJ Talley, GN Tytgat, NA Wright, Aliment Pharmacol Ther. 2006 Mar 15:683-90 |
||
| Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection. T Suzuki, K Matsuo, A Sawaki, H Ito, K Hirose, K Wakai, S Sato, T Nakamura, K Yamao, R Ueda, K Tajima, Aliment Pharmacol Ther. 2006 Jul 15:273-80 |
||
| Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. L Fuccio, RM Zagari, ME Minardi, F Bazzoli, Aliment Pharmacol Ther. 2007 Jan 15:133-41 |
||
| The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. C Wang, Y Yuan, RH Hunt, Am J Gastroenterol. 2007 Aug:1789-98 |
||
| The Relationship Between Virulence Factors of Helicobacter pylori and Severity of Gastritis in Infected Patients. Umit H, Tezel A, Bukavaz S, Unsal G, Otkun M, Soylu AR, Tucer D, Otkun M, Bilgi S, Dig Dis Sci 2009 Jan;54(1):103-10 |
||
| Supplementary evidence: | ||
| Accuracy of a new ultrafast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive dyspeptic patients. Vaira D, Vakil N, Gatta L, Ricci C, Perna F, Saracino I, Fiorini G, Holton J, Aliment Pharmacol Ther. 2010 Jan 15;31(2):331-8 |
||
| Gastroesophageal reflux symptoms in a Danish population: a prospective follow-up analysis of symptoms, quality of life, and health-care use. Hansen JM, Wildner-Christensen M, Schaffalitzky de Muckadell OB, Am J Gastroenterol. 2009 Oct;104(10):2394-403 |
||
| Basis for the management of drug-resistant Helicobacter pylori infection. F Mégraud, Drugs. 2004:1893-904 |
||
| Diagnosis of Helicobacter pylori infection. A Makristathis, AM Hirschl, P Lehours, F Mégraud, Helicobacter. 2004:7-14 |
||
| Eradication of Helicobacter pylori for non-ulcer dyspepsia. P Moayyedi, S Soo, J Deeks, B Delaney, A Harris, M Innes, R Oakes, S Wilson, A Roalfe, C Bennett, D Forman, Cochrane Database Syst Rev. 2006:CD002096 |
||
| Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. AC Ford, BC Delaney, D Forman, P Moayyedi, Cochrane Database Syst Rev. 2006:CD003840 |
||
| H pylori antibiotic resistance: prevalence, importance, and advances in testing. F Mégraud, Gut. 2004 Sep:1374-84 |
||
| Helicobacter pylori and nonmalignant diseases. EJ Kuipers, P Malfertheiner, Helicobacter. 2004:29-34 |
||
| Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. P Malfertheiner, P Sipponen, M Naumann, P Moayyedi, F Mégraud, SD Xiao, K Sugano, O Nyrén, Lejondal H. pylori-Gastric Cancer Task Force, Am J Gastroenterol. 2005 Sep:2100-15 |
||
| Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. BC Wong, SK Lam, WM Wong, JS Chen, TT Zheng, RE Feng, KC Lai, WH Hu, ST Yuen, SY Leung, DY Fong, J Ho, CK Ching, JS Chen, China Gastric Cancer Study Group, JAMA. 2004 Jan 14:187-94 |
||
| Helicobacter pylori public health implications. P Moayyedi, RH Hunt, Helicobacter. 2004:67-72 |
||
| New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study. LG Coelho, LD Moretzsohn, WL Vieira, MA Gallo, MC Passos, JM Cindr, MC Cerqueira, L Vitiello, ML Ribeiro, S Mendonça, J Pedrazzoli-Júnior, LP Castro, Aliment Pharmacol Ther. 2005 Mar 15:783-7 |
||
| Review article: C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review. JP Gisbert, JM Pajares, Aliment Pharmacol Ther. 2004 Nov 15:1001-17 |
||
| Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing RH Hunt, F Bazzoli, Aliment Pharmacol Ther. 2004 Feb:9-16 |
||
| The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area. LY Zhou, SR Lin, SG Ding, XB Huang, L Zhang, LM Meng, RL Cui, J Zhu, Chin J Dig Dis. 2005:114-5 |
||
| Will eradication of Helicobacter pylori infection influence the risk of gastric cancer? RH Hunt, Am J Med. 2004 Sep 6:86S-91S |
||